創力集團(603012.SH):擬發行可轉債募資不超5.7億元 用於收購中煤科技36.04%股權等
格隆匯9月16日丨創力集團(603012.SH)公佈公開發行可轉換公司債券預案,此次擬發行可轉債總額不超過人民幣5.7億元(含5.7億元),具體數額由股東大會授權公司董事會在上述額度範圍內確定。
此次發行的可轉債按面值發行,每張面值為人民幣100元。此次發行的可轉債期限為自發行之日起六年。
公司此次公開發行可轉換公司債券的募集資金總額不超過5.7億元(含5.7億元),扣除發行費用後,擬4億元用於收購浙江中煤機械科技有限公司36.04%股權,擬1.7億元用於補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.